Close Menu

This article has been updated from a previous version to include comments made by Qiagen CEO Peer Schatz during a conference call recapping the company's earnings.

NEW YORK (GenomeWeb) – Qiagen said after the close of the market on Wednesday that its fourth quarter revenues grew 8 percent year over year as the firm beat analysts' consensus estimates on the top and bottom lines.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Bloomberg reports that the DNA-for-cash deal reported in Kentucky might be a more widespread scam.

St. Jude Children's Research Hospital scientists have treated infants with X-linked severe combined immunodeficiency using gene therapy in an early phase study.

St. Louis Public Radio reports that some African Americans are turning to DNA ancestry testing to help guide genealogical searches.

In Nature this week: a genomic analysis of the snailfish Pseudoliparis swirei, ancient DNA analysis gives insight into the introduction of farming to England, and more.